Skip to main content
Top

Open Access 24-04-2025 | Sexually Transmitted Infection | Original Paper

Sexually Transmitted Infection (STI) Incidence and Risk Factors Among People with HIV (PWH): Insights from a 13-Year Cohort Study in South Carolina

Authors: Salome-Joelle Gass, Shujie Chen, Jiajia Zhang, Bankole Olatosi

Published in: AIDS and Behavior

Login to get access

Abstract

The Ending the HIV Epidemic (EHE) initiative aims to reduce new HIV infections by 90% by 2030 in the United States (US). However, rising sexually transmitted infection (STI) rates exacerbate the bidirectional infection risk between HIV and STIs. Most research on STIs among people with HIV (PWH) has focused on high-risk groups, resulting in limited data on broader populations. This study addresses that gap by examining the incidence and risk factors for gonorrhea, chlamydia, and syphilis in a statewide cohort of PWH in South Carolina. Data from South Carolina’s HIV and STI surveillance systems were linked, and all PWH aged 18 and older who were diagnosed with HIV between 2007 to April 2018 were included. Cohort demographics were analyzed using descriptive statistics and chi-squared tests, and a Cox Proportional Hazards model examined time to first STI after HIV diagnosis. The study found an increase in the incidence of gonorrhea, chlamydia, and syphilis over the study period. Young adults, men, Black individuals, MSM, and urban residents were found to be at increased risk for STI diagnosis. Clinical risk factors associated with increased STI risk included lower initial CD4 counts, and higher initial viral loads. The findings underscore a considerable STI burden among PWH in South Carolina. To mitigate STI transmission in the context of HIV, targeted interventions for high-risk populations are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference CDC. Fast facts: HIV in the United States. 2024. CDC. Fast facts: HIV in the United States. 2024.
2.
go back to reference Sullivan PS, Woodyatt C, Koski C, et al. A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource. J Med Internet Res. 2020;22(10):e23173.CrossRefPubMedPubMedCentral Sullivan PS, Woodyatt C, Koski C, et al. A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource. J Med Internet Res. 2020;22(10):e23173.CrossRefPubMedPubMedCentral
3.
go back to reference Cohen MS. Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis. 2012;206(1):1–2.CrossRefPubMed Cohen MS. Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis. 2012;206(1):1–2.CrossRefPubMed
4.
go back to reference Bosetti D, Mugglin C, Calmy A, et al. Risk factors and incidence of sexually transmitted infections in the swiss HIV cohort study. Open Forum Infect Dis. 2022;9:12.CrossRef Bosetti D, Mugglin C, Calmy A, et al. Risk factors and incidence of sexually transmitted infections in the swiss HIV cohort study. Open Forum Infect Dis. 2022;9:12.CrossRef
5.
go back to reference Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Trans Infect. 2011;87(3):183–90.CrossRef Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Trans Infect. 2011;87(3):183–90.CrossRef
6.
go back to reference Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019;22:6.CrossRef Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019;22:6.CrossRef
7.
go back to reference Manning SE, Pfeiffer MR, Nash D, Blank S, Sackoff J, Schillinger J. Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001–2002: a population-based assessment. Sex Trans Dis. 2007;34(12):1008–15.CrossRef Manning SE, Pfeiffer MR, Nash D, Blank S, Sackoff J, Schillinger J. Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001–2002: a population-based assessment. Sex Trans Dis. 2007;34(12):1008–15.CrossRef
8.
go back to reference CDC. National Overview of STIs, 2022. 2024. CDC. National Overview of STIs, 2022. 2024.
9.
go back to reference CDC. Incidence, prevalence, and cost of sexually transmitted infections in the United States, 2018. 2024; https://www.cdc.gov/nchhstp-newsroom/factsheets/incidence-prevalence-cost-stis-in-us.html. CDC. Incidence, prevalence, and cost of sexually transmitted infections in the United States, 2018. 2024; https://​www.​cdc.​gov/​nchhstp-newsroom/​factsheets/​incidence-prevalence-cost-stis-in-us.​html.​
10.
go back to reference Spaulding AB, Lifson AR, Iverson ER, et al. Gonorrhoea or chlamydia in a US military HIV-positive cohort. Sex Trans Infect. 2012;88(4):266–71.CrossRef Spaulding AB, Lifson AR, Iverson ER, et al. Gonorrhoea or chlamydia in a US military HIV-positive cohort. Sex Trans Infect. 2012;88(4):266–71.CrossRef
11.
go back to reference Lucar J, Hart R, Rayeed N, et al. Sexually transmitted infections among HIV-infected individuals in the District of Columbia and estimated HIV transmission risk: data from the DC cohort. Open Forum Infect Dis. 2018;5:2.CrossRef Lucar J, Hart R, Rayeed N, et al. Sexually transmitted infections among HIV-infected individuals in the District of Columbia and estimated HIV transmission risk: data from the DC cohort. Open Forum Infect Dis. 2018;5:2.CrossRef
12.
go back to reference Menza TW, Berry SA, Dombrowski J, et al. Anatomic site-specific gonorrhea and chlamydia testing and incidence among people with HIV engaged in care at 4 US clinical centers, 2014–2018. Open Forum Infect Dis. 2022;9:7.CrossRef Menza TW, Berry SA, Dombrowski J, et al. Anatomic site-specific gonorrhea and chlamydia testing and incidence among people with HIV engaged in care at 4 US clinical centers, 2014–2018. Open Forum Infect Dis. 2022;9:7.CrossRef
13.
go back to reference Tu W, Li Y-Y, Kuang Y-Q, et al. High prevalence of sexually transmitted infections and risk factors among HIV-positive individuals in Yunnan, China. Eur J Med Re. 2022;27:1. Tu W, Li Y-Y, Kuang Y-Q, et al. High prevalence of sexually transmitted infections and risk factors among HIV-positive individuals in Yunnan, China. Eur J Med Re. 2022;27:1.
14.
go back to reference Li J, Armon C, Palella FJ, et al. Chlamydia and gonorrhea incidence and testing among patients in the human immunodeficiency virus outpatient study (HOPS), 2007–2017. Clin Infect Dis. 2020;71(8):1824–35.CrossRefPubMed Li J, Armon C, Palella FJ, et al. Chlamydia and gonorrhea incidence and testing among patients in the human immunodeficiency virus outpatient study (HOPS), 2007–2017. Clin Infect Dis. 2020;71(8):1824–35.CrossRefPubMed
15.
go back to reference Secco AA, Akselrod H, Czeresnia J, et al. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC cohort. Sex Trans Infect. 2020;96(2):89–95.CrossRef Secco AA, Akselrod H, Czeresnia J, et al. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC cohort. Sex Trans Infect. 2020;96(2):89–95.CrossRef
16.
go back to reference Crowley JS, Geller AB, Vermund SH (eds) Sexually transmitted infections: adopting a sexual health paradigm. Washington (DC) 2021. Crowley JS, Geller AB, Vermund SH (eds) Sexually transmitted infections: adopting a sexual health paradigm. Washington (DC) 2021.
17.
go back to reference Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav. 2018;164:125–38.CrossRefPubMed Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav. 2018;164:125–38.CrossRefPubMed
18.
go back to reference Baltes V, de Boissieu P, Champenois K, et al. Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study. J Int AIDS Soc. 2024;27:3.CrossRef Baltes V, de Boissieu P, Champenois K, et al. Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study. J Int AIDS Soc. 2024;27:3.CrossRef
19.
go back to reference Blackwell CW, Preventing HIV. Infection in high-risk adolescents using pre-exposure prophylaxis (PrEP). J Assoc Nurses AIDS Care. 2018;29(5):770–4.CrossRefPubMed Blackwell CW, Preventing HIV. Infection in high-risk adolescents using pre-exposure prophylaxis (PrEP). J Assoc Nurses AIDS Care. 2018;29(5):770–4.CrossRefPubMed
20.
go back to reference CDC. Pre-exposure prophylaxis for the prevention of HIV infection in the United States–2017 Update: a clinical practice guideline 2018. CDC. Pre-exposure prophylaxis for the prevention of HIV infection in the United States–2017 Update: a clinical practice guideline 2018.
21.
go back to reference Owens DK, Davidson KW, Krist AH, et al. Pre-exposure prophylaxis for the prevention of HIV infection. Jama. 2019;321:22. Owens DK, Davidson KW, Krist AH, et al. Pre-exposure prophylaxis for the prevention of HIV infection. Jama. 2019;321:22.
22.
go back to reference Holt M, Murphy DA. Individual versus community-level risk compensation following pre-exposure prophylaxis of HIV. Am J Public Health. 2017;107(10):1568–71.CrossRefPubMedPubMedCentral Holt M, Murphy DA. Individual versus community-level risk compensation following pre-exposure prophylaxis of HIV. Am J Public Health. 2017;107(10):1568–71.CrossRefPubMedPubMedCentral
23.
go back to reference Wilson NL, Xiong W, Mattson CL. Is sex like driving? HIV prevention and risk compensation. J Dev Econ. 2014;106:78–91.CrossRefPubMed Wilson NL, Xiong W, Mattson CL. Is sex like driving? HIV prevention and risk compensation. J Dev Econ. 2014;106:78–91.CrossRefPubMed
24.
go back to reference Hojilla JC, Marcus J, Volk JE, et al. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Trans Infect. 2020;96(3):184–8.CrossRef Hojilla JC, Marcus J, Volk JE, et al. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Trans Infect. 2020;96(3):184–8.CrossRef
25.
go back to reference Traeger MW, Guy R, Asselin J, et al. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data. Lancet Infect Dis. 2022;22(8):1231–41.CrossRefPubMed Traeger MW, Guy R, Asselin J, et al. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data. Lancet Infect Dis. 2022;22(8):1231–41.CrossRefPubMed
26.
go back to reference Holt M, Broady TR, Mao L, et al. Increasing pre-exposure prophylaxis use and ‘net prevention coverage’ in behavioural surveillance of Australian gay and bisexual men. Aids. 2021;35(5):835–40.CrossRefPubMed Holt M, Broady TR, Mao L, et al. Increasing pre-exposure prophylaxis use and ‘net prevention coverage’ in behavioural surveillance of Australian gay and bisexual men. Aids. 2021;35(5):835–40.CrossRefPubMed
27.
go back to reference Thompson EL, Griner SB, Galvin AM, Lowery AD, Lewis MA. Correlates of STI testing among US young adults: opportunities for prevention. Prevent Sci. 2020;22(2):216–26.CrossRef Thompson EL, Griner SB, Galvin AM, Lowery AD, Lewis MA. Correlates of STI testing among US young adults: opportunities for prevention. Prevent Sci. 2020;22(2):216–26.CrossRef
28.
go back to reference Haider MR, Kingori C, Brown MJ, Battle-Fisher M, Chertok IA. Illicit drug use and sexually transmitted infections among young adults in the US: evidence from a nationally representative survey. Int J STD AIDS. 2020;31(13):1238–46.CrossRefPubMedPubMedCentral Haider MR, Kingori C, Brown MJ, Battle-Fisher M, Chertok IA. Illicit drug use and sexually transmitted infections among young adults in the US: evidence from a nationally representative survey. Int J STD AIDS. 2020;31(13):1238–46.CrossRefPubMedPubMedCentral
29.
go back to reference Voyiatzaki C, Venetikou MS, Papageorgiou E, et al. Awareness, knowledge and risky behaviors of sexually transmitted diseases among young people in Greece. Int J Environ Res Public Health. 2021;18:19.CrossRef Voyiatzaki C, Venetikou MS, Papageorgiou E, et al. Awareness, knowledge and risky behaviors of sexually transmitted diseases among young people in Greece. Int J Environ Res Public Health. 2021;18:19.CrossRef
30.
go back to reference McHaro RD, Olomi W, Mayaud P, Msuya SE. Risky sexual behaviours among young adults attending higher learning institutions in Mbeya, Tanzania: implications for STIs and HIV preventive programs. Open Res Africa. 2021;3:9.CrossRef McHaro RD, Olomi W, Mayaud P, Msuya SE. Risky sexual behaviours among young adults attending higher learning institutions in Mbeya, Tanzania: implications for STIs and HIV preventive programs. Open Res Africa. 2021;3:9.CrossRef
31.
go back to reference Boutrin M-C, Williams DR. What racism has to do with it: understanding and reducing sexually transmitted diseases in youth of color. Healthcare. 2021;9:6.CrossRef Boutrin M-C, Williams DR. What racism has to do with it: understanding and reducing sexually transmitted diseases in youth of color. Healthcare. 2021;9:6.CrossRef
32.
go back to reference Cohn T, Harrison CV. A systematic review exploring racial disparities, social determinants of health, and sexually transmitted infections in black women. Nurs Women’s Health. 2022;26(2):128–42.CrossRef Cohn T, Harrison CV. A systematic review exploring racial disparities, social determinants of health, and sexually transmitted infections in black women. Nurs Women’s Health. 2022;26(2):128–42.CrossRef
33.
go back to reference Giannouchos TV, Crouch E, Merrell MA, Brown MJ, Harrison SE, Pearson WS. Racial, ethnic, and rural/urban disparities in hiv and sexually transmitted infections in South Carolina. J Commun Health. 2022;48(1):152–9.CrossRef Giannouchos TV, Crouch E, Merrell MA, Brown MJ, Harrison SE, Pearson WS. Racial, ethnic, and rural/urban disparities in hiv and sexually transmitted infections in South Carolina. J Commun Health. 2022;48(1):152–9.CrossRef
34.
go back to reference Scott-Sheldon LAJ, Chan PA. Increasing sexually transmitted infections in the US: a call for action for research, clinical, and public health practice. Arch Sex Behav. 2019;49(1):13–7.CrossRef Scott-Sheldon LAJ, Chan PA. Increasing sexually transmitted infections in the US: a call for action for research, clinical, and public health practice. Arch Sex Behav. 2019;49(1):13–7.CrossRef
35.
go back to reference Rosenbaum JE, Cullinen K, Hill M, et al. Improving sexually transmitted infection screening, testing, and treatment among people with HIV: A mixed method needs assessment to inform a multi-site, multi-level intervention and evaluation plan. Plos One. 2021;16:12. Rosenbaum JE, Cullinen K, Hill M, et al. Improving sexually transmitted infection screening, testing, and treatment among people with HIV: A mixed method needs assessment to inform a multi-site, multi-level intervention and evaluation plan. Plos One. 2021;16:12.
36.
go back to reference Gilbert L, Goddard-Eckrich D, Chang M, et al. Effectiveness of a culturally tailored hiv and sexually transmitted infection prevention intervention for black women in community supervision programs. JAMA Netw Open. 2021;4:4.CrossRef Gilbert L, Goddard-Eckrich D, Chang M, et al. Effectiveness of a culturally tailored hiv and sexually transmitted infection prevention intervention for black women in community supervision programs. JAMA Netw Open. 2021;4:4.CrossRef
37.
go back to reference Price MA, Donenberg GR, Kendall AD, et al. IMARA: A mother-daughter group randomized controlled trial to reduce sexually transmitted infections in Black/African-American adolescents. Plos One. 2020;15:11. Price MA, Donenberg GR, Kendall AD, et al. IMARA: A mother-daughter group randomized controlled trial to reduce sexually transmitted infections in Black/African-American adolescents. Plos One. 2020;15:11.
Metadata
Title
Sexually Transmitted Infection (STI) Incidence and Risk Factors Among People with HIV (PWH): Insights from a 13-Year Cohort Study in South Carolina
Authors
Salome-Joelle Gass
Shujie Chen
Jiajia Zhang
Bankole Olatosi
Publication date
24-04-2025
Publisher
Springer US
Published in
AIDS and Behavior
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-025-04744-5

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar